Mark Houston, MD, MS, FAHA, FASH, DABC; Internist & Cardiovascular Specialist; Director, Hypertension Institute and Vascular Biology
The diagnosis, evaluation, and treatment of dyslipidemia have been misdirected for the past 30-40 years. Dr. Houston presents an evolutionary approach to managing dyslipidemia and dyslipidemia-induced vascular disease by challenging the use of LDL and triglycerides as markers of disease. In this talk he shares new approaches to manage the dyslipidemia epidemic.
REGISTER AND WATCH THE FULL VIDEO.
Click here for a full list of upcoming MAPS events.
